Sequence Plasticity in the Antigen-binding Site of a Therapeutic Anti-HER2 Antibody

By Gerstner R.B.   Carter P.   Lowman H.B.  

Journal of Molecular Biology, Vol. 321, Iss. 5, 2002-08 ,pp. : 851-862

Academic Press

Access to resources Recommend Favorite

Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding Site

By Schier R.   McCall A.   Adams G.P.   Marshall K.W.   Merritt H.   Yim M.   Crawford R.S.   Weiner L.M.   Marks C.   Marks J.D.  

Journal of Molecular Biology, Vol. 263, Iss. 4, 1996-11 ,pp. : 551-567

Academic Press

Access to resources Recommend Favorite

A Bivalent Disulfide-stabilized Fv with Improved Antigen Binding to erbB2

By Bera T.K.   Onda M.   Brinkmann U.   Pastan I.  

Journal of Molecular Biology, Vol. 281, Iss. 3, 1998-08 ,pp. : 475-483

Academic Press

Access to resources Recommend Favorite

Biological Effects of Anti-ErbB2 Single Chain Antibodies Selected for Internalizing Function

By Neve R.M.   Nielsen U.B.   Kirpotin D.B.   Poul M-A.   Marks J.D.   Benz C.C.  

Biochemical and Biophysical Research Communications, Vol. 280, Iss. 1, 2001-01 ,pp. : 274-279

Elsevier

Access to resources Recommend Favorite

Intracellular Expression of the Anti-erbB-2 sFv N29 Fails to Accomplish Efficient Target Modulation

By Grim J.E.   Siegal G.P.   Alvarez R.D.   Curiel D.T.  

Biochemical and Biophysical Research Communications, Vol. 250, Iss. 3, 1998-09 ,pp. : 699-703

Elsevier

Access to resources Recommend Favorite